Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

Go back to Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.87 +0.03 (0.25%)
Previous Close $11.84    52 Week High $2.18 
Open $12.09    52 Week Low $0.30 
Day High $12.18    P/E N/A 
Day Low $11.73    EPS $-3.32 
Volume 255,241       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 11.87 +0.03 (0.25%)
Previous Close $11.84    52 Week High $2.18 
Open $12.09    52 Week Low $0.30 
Day High $12.18    P/E N/A 
Day Low $11.73    EPS $-3.32 
Volume 255,241